NeoGenomics
261 hedge funds and large institutions have $2.73B invested in NeoGenomics in 2019 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 90 increasing their positions, 80 reducing their positions, and 39 closing their positions.
78% more call options, than puts
Call options by funds: $5.02M | Put options by funds: $2.83M
66% more capital invested
Capital invested by funds: $1.65B → $2.73B (+$1.09B)
43% more funds holding in top 10
Funds holding in top 10: 7 → 10 (+3)
41% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 39
13% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 80
5.47% more ownership
Funds ownership: 84.05% → 89.51% (+5.5%)
3% more funds holding
Funds holding: 253 → 261 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$20.3M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$16.8M |
| 3 |
RI
Redwood Investments
Boston,
Massachusetts
|
+$14.2M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$12.6M |
| 5 |
BlackRock
New York
|
+$6.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$7.87M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$7.1M |
| 3 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$5.84M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$5.59M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$4.95M |
NEO Hedge Fund Activity: Q4 2019 in Review
261 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2019, worth a combined $2.73B — up 66% from $1.65B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new NEO positions and 39 closed out — a net gain of 16 holders — while 90 added to existing stakes and 80 trimmed.
The largest buyer was Invesco, adding an estimated $20.3M. The largest seller was Emerald Mutual Fund Advisers Trust, cutting an estimated $7.87M.
- 261 institutional investors held NeoGenomics (NEO) as of Q4 2019, up from 253 in Q3 2019.
- Funds reported $2.73B of NeoGenomics stock for Q4 2019, up 66% quarter-over-quarter.
- 55 funds opened new NeoGenomics positions in Q4 2019 and 39 closed out, a net change of +16 holders.
- The largest NeoGenomics buyer in Q4 2019 was Invesco, an estimated $20.3M added.
- The largest NeoGenomics seller in Q4 2019 was Emerald Mutual Fund Advisers Trust, an estimated $7.87M sold.
Based on aggregated 13F filings for Q4 2019.